series-a
Stage
2
Investors
About
Champions Oncology provides specialized preclinical services using patient-derived xenograft (PDX) models to support oncology drug development and personalized cancer treatment.
Explore Champions Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.